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We propose an equilibrium analysis of a dynamical model of yellow fever transmission in the presence of a vaccine. The model
considers both human and vector populations. We found thresholds parameters that affect the development of the disease and the
infectious status of the human population in the presence of a vaccine whose protection may wane over time. In particular, we
derived a threshold vaccination rate, above which the disease would be eradicated from the human population. We show that if the
mortality rate of the mosquitoes is greater than a given threshold, then the disease is naturally (without intervention) eradicated
from the population. In contrast, if the mortality rate of the mosquitoes is less than that threshold, then the disease is eradicated
from the populations only when the growing rate of humans is less than another threshold; otherwise, the disease is eradicated only
if the reproduction number of the infection after vaccination is less than 1. When this reproduction number is greater than 1, the
disease will be eradicated from the human population if the vaccination rate is greater than a given threshold; otherwise, the disease
will establish itself among humans, reaching a stable endemic equilibrium.The analysis presented in this paper can be useful, both
to the better understanding of the disease dynamics and also for the planning of vaccination strategies.
1. Introduction
Yellow fever (YF), a hemorrhagic fever caused by a Flavivirus,
family Flaviviridae [1, 2], is characterized by fever, chills, loss
of appetite, nausea, muscle pains particularly in the back,
and headaches [3]. There are more than 200,000 infections
and 30,000 deaths every year [3]. About 90% of YF cases
occur in Africa [4], and a billion people live in an area of
the world where the disease is common [3]. It also affects
tropical areas of South America, but not Asia [3, 5, 6]. The
number of cases of yellow fever has been increasing in the last
30 years [3, 7], probably due to fewer people being immune,
more people living in cities, people moving frequently, and
changing climate [3].The origin of the disease is Africa, from
where it spread in South America through the slave trade in
the 17th century [8, 9].
The yellow fever virus was the first human virus discov-
ered [10], and its family comprises approximately 70 viruses
[2], most of which are transmitted by arthropod insects
(hence the name arthropod borne viruses or arboviruses).
A safe and effective vaccine against yellow fever exists
and some countries require vaccinations for travelers [3].
In rare cases (less than one in 200,000 to 300,000 doses),
the vaccination can cause yellow fever vaccine-associated
viscerotropic disease (YEL-AVD), which is fatal in 60% of
cases, probably due to the geneticmorphology of the immune
system. Another possible side effect is an infection of the
nervous system, which occurs in one in 200,000 to 300,000
cases, causing yellow fever vaccine-associated neurotropic
disease (YEL-AND), which can lead to meningoencephalitis,
fatal in less than 5% of cases [6]. In some rare circum-
stances, however, the fatality rate of vaccine induced diseases
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can reach alarming proportions, as observed recently by
Mascheretti et al. [11], who found 1 death per million doses
applied in a Southeastern Brazilian region.
In this paper, we propose an equilibrium analysis of a
dynamicalmodel of yellow fever transmission in the presence
of a vaccine. Such a kind of analysis can be useful, both to the
better understanding of the disease dynamics and also for the
planning of vaccination strategies.
2. Model Formulation
The mathematical model described below addresses the
transmission dynamics of an infectious agent in a homoge-
neous population in the presence of an imperfect vaccine.
We consider a nonlinear system of ordinary differential
equations involving the human and the vector—mosquitoes
and their eggs—populations. The term “eggs” also includes
the intermediate stages, such as larvae and pupae. It is also
worth highlighting that the model proposed here is based on
previous papers [12, 13], and we updated the model originally
developed by Amaku et al., 2013 [14, 15], for the purpose
of investigating the impact of vaccination on population. By
including vaccination, in particular vaccines which may have
serious adverse effects, the model may help the designing of
realistic (from the cost and logistic point of view) vaccination
strategies.
All variables and parameters in the human system will
carry the subscript 𝐻, while those in the vector system will
carry one of the subscripts 𝑀 (mosquitoes) or 𝐸 (eggs). In
our model the total human population, denoted by 𝑁
𝐻
,
is split into four subclasses which are susceptible humans
(𝑆
𝐻
), vaccinated humans (𝑉
𝐻
), infected humans (𝐼
𝐻
), and
recovered (and immune) humans (𝑅
𝐻
), so that 𝑁
𝐻
= 𝑆
𝐻
+
𝐼
𝐻
+ 𝑅
𝐻
+ 𝑉
𝐻
. The total vector population, which is formed
by both totalmosquitoes population, denoted by 𝑁
𝑀
, and the
total eggs population, denoted by 𝑁
𝐸
, are split into suscepti-
ble mosquitoes (𝑆
𝑀
), infected and latent mosquitoes (𝐿
𝑀
),
infected and infectious mosquitoes (𝐼
𝑀
), and noninfected
eggs (𝑆
𝐸
), so that 𝑁
𝑀
= 𝑆
𝑀
+ 𝐿
𝑀
+ 𝐼
𝑀
and 𝑁
𝐸
= 𝑆
𝐸
.
A flow diagram of the model is depicted in Figure 1,
and the associated variables and parameters are described in
Tables 1 and 2, respectively (values from references [16–22]).
The model supposes a homogeneous mixing of human
andmosquito population based on the idea that themosquito
has a human biting habit, so that each mosquito bite has an
equal probability of transmitting the virus to the susceptible
human in the population or acquiring infection from an
infected human. The equations are derived based on the
fact that, in presence of the yellow fever in the population,
both mosquitoes and humans can infect each other upon
contact. While an infected mosquito remains infected until
death, it is assumed that infected humans can recover from
the disease (see [23]). We define a logistic recruitment
rate of humans, mosquitoes, and eggs, and all new born
humans and newly emerged mosquitoes are susceptible (no
vertical transmission; see [23]). Susceptible humans become
infected through the bite by an infected mosquito and the
susceptible mosquitoes become latent infected as result of
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Figure 1: Schematic diagram of the yellow fever model (1).
Table 1: Description of the variables of the yellow fever model (1).
Variable Biological meaning
𝑆
𝐻 Density of susceptible humans
𝑉
𝐻 Density of vaccinated humans
𝐼
𝐻 Density of infected humans
𝑅
𝐻 Density of recovered humans
𝑁
𝐻 Density of total human population
𝑆
𝑀 Density of uninfected mosquitoes
𝐿
𝑀 Density of latent mosquitoes
𝐼
𝑀 Density of infected mosquitoes
𝑁
𝑀 Density of total mosquitoes population
𝑆
𝐸 Density of uninfected aquatic forms∗
𝑁
𝐸 Density of total aquatic forms∗
∗Those variables are called “aquatic” because mosquitoes spend the large
period of their development history in the water [25].
biting infectious humans. Upon acquiring infection, the
susceptible individuals move into the infected compartment.
The incidence of new infections is given by the standard
incidence (see [24, pp. 602]).
Deaths can occur amongst the human population,
mosquitoes, and eggs, naturally. In contrast, in the presence
of the yellow fever, the human population can either die due
to the additional effects of the disease or recover. It is also
assumed that recovered human individuals acquire immunity
against reinfection, so that they do not acquire yellow fever
for a second time.
Although there is a vaccine for yellow fever, it is expected
that it is imperfect; that is, it does not offer 100% protection
against infection in all population. Thus, it is instructive
to assess the potential impact of an imperfect yellow fever
vaccine.
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Table 2: Description of the parameters of the yellow fevermodel (1).
Parameter Biological meaning Value (baseline)
𝑎 Average daily biting rate 3.0
𝑏
Fraction of actually infective
bites(+) 0.6
𝜇
𝐻
Humans natural mortality rate 3.5 × 10−5 days−1
𝑟
𝐻
Birth rate of humans 9.5 × 10−5 days−1
𝑘
𝐻
Humans carrying capacity 5 × 106
𝛼
𝐻
Yellow fever mortality in
humans 3.5 × 10
−4 days−1
𝛾
𝐻
Humans recovery rate 0.143 days−1
𝑝 Susceptible eggs hatching rate 0.15 days−1
𝜔
𝐻
Rate of waning of immunity
induced by vaccination 0.1 days
−1
𝜐
𝐻
Vaccination rate 0.5
𝑓
𝐻
Vaccine efficacy 0.9
𝛾
𝑀
Mosquitoes latency rate 0.143 days−1
𝜇
𝑀
Mosquitoes natural mortality
rate 0.09 days
−1
𝑟
𝑀
Oviposition rate 50 days−1
𝑘
𝐸
Aquatic carrying capacity 9.8 × 107
𝜇
𝐸
Aquatic natural mortality rate 0.1 days−1
𝑐
A. aegypti susceptibility to
yellow fever(&) 0.8
𝑐
𝑆
Climatic factor(#) 0.07
(+)Probability that an infective bite generates a new infection in humans.
(&)Probability that a new infection in the mosquito is generated when it bites
an infective host.
(#)Ad hoc parameter that modulates seasonality.
After the duration of protection wanes down, the vacci-
nated individuals, 𝑉
𝐻
, move to the susceptible class, 𝑆
𝐻
, and
theymay then acquire a new infection. Hence, the vaccinated
population is decreased by the waning of vaccine-induced
immunity and by natural death.
Combining the above formulation and assumption, it
follows that the model for the transmission dynamics of
the yellow fever disease in the presence of an imperfect
vaccine is given by the following systemof nonlinear ordinary
differential equations:
𝑑𝑆
𝐻
𝑑𝑡
= − 𝑎𝑏𝐼
𝑀
𝑆
𝐻
𝑁
𝐻
− 𝜇
𝐻
𝑆
𝐻
+ 𝑟
𝐻
𝑁
𝐻
(1 −
𝑁
𝐻
𝜅
𝐻
)
− 𝑓
𝐻
𝜐
𝐻
𝑆
𝐻
+ 𝜔
𝐻
𝑉
𝐻
,
𝑑𝑉
𝐻
𝑑𝑡
= 𝑓
𝐻
𝜐
𝐻
𝑆
𝐻
− (𝜇
𝐻
+ 𝜔
𝐻
) 𝑉
𝐻
,
𝑑𝐼
𝐻
𝑑𝑡
= 𝑎𝑏𝐼
𝑀
𝑆
𝐻
𝑁
𝐻
− (𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) 𝐼
𝐻
,
𝑑𝑅
𝐻
𝑑𝑡
= 𝛾
𝐻
𝐼
𝐻
− 𝜇
𝐻
𝑅
𝐻
,
𝑑𝑁
𝐻
𝑑𝑡
= 𝑟
𝐻
𝑁
𝐻
(1 −
𝑁
𝐻
𝜅
𝐻
) − 𝜇
𝐻
𝑁
𝐻
− 𝛼
𝐻
𝐼
𝐻
,
𝑑𝑆
𝑀
𝑑𝑡
= 𝑝𝑐
𝑆
𝑆
𝐸
− (𝜇
𝑀
+ 𝑎𝑐
𝐼
𝐻
𝑁
𝐻
) 𝑆
𝑀
,
𝑑𝐿
𝑀
𝑑𝑡
= 𝑎𝑐𝑆
𝑀
𝐼
𝐻
𝑁
𝐻
− (𝛾
𝑀
+ 𝜇
𝑀
) 𝐿
𝑀
,
𝑑𝐼
𝑀
𝑑𝑡
= 𝛾
𝑀
𝐿
𝑀
− 𝜇
𝑀
𝐼
𝑀
,
𝑑𝑁
𝑀
𝑑𝑡
= 𝑝𝑐
𝑆
𝑆
𝐸
− 𝜇
𝑀
𝑁
𝑀
,
𝑑𝑆
𝐸
𝑑𝑡
= 𝑟
𝑀
𝑁
𝑀
(1 −
𝑆
𝐸
𝜅
𝐸
) − (𝜇
𝐸
+ 𝑝𝑐
𝑆
) 𝑆
𝐸
(1)
with the conditions 𝑁
𝐻
= 𝑆
𝐻
+ 𝑉
𝐻
+ 𝐼
𝐻
+ 𝑅
𝐻
, 𝑁
𝑀
=
𝑆
𝑀
+ 𝐿
𝑀
+ 𝐼
𝑀
, and 𝑁
𝐸
= 𝑆
𝐸
and the initial conditions
𝑆
𝐻
(0) ≥ 0, 𝑉
𝐻
(0) ≥ 0, 𝐼
𝐻
(0) ≥ 0, 𝑅
𝐻
(0) ≥ 0, 𝑆
𝑀
(0) ≥
0, 𝐿
𝑀
(0) ≥ 0, 𝐼
𝑀
(0) ≥ 0, 𝑁
𝑀
(0) ≥ 0, and 𝑆
𝐸
(0) ≥
0. Note that the transmission from mosquitoes to humans
is given by 𝑎𝑏(𝐼
𝑀
/𝑁
𝐻
) (also called “force of infection”)
and from humans to mosquitoes is given by 𝑎𝑐(𝐼
𝐻
/𝑁
𝐻
).
This means that the transmission from mosquito to humans
depends on the number of infective mosquitoes, but the
transmission from human to mosquitoes depends on the
density of infective humans.
Since system (1) models human, mosquito, and eggs
populations, it is assumed that all variables in the system are
nonnegative. This assumption yields the epidemiologically
feasible domain:
Ω = {(𝑆
𝐻
, 𝑉
𝐻
, 𝐼
𝐻
, 𝑅
𝐻
, 𝑆
𝑀
, 𝐿
𝑀
, 𝐼
𝑀
, 𝑆
𝐸
) ∈ 𝑅
8:
𝑆
𝐻
≥ 0, 𝑉
𝐻
≥ 0, 𝐼
𝐻
≥ 0, 𝑅
𝐻
≥ 0,
0 ≤ 𝑆
𝐻
+ 𝑉
𝐻
+ 𝐼
𝐻
+ 𝑅
𝐻
≤ 𝑁
𝐻
, 𝑆
𝑀
≥ 0,
𝐿
𝑀
≥ 0, 𝐼
𝑀
≥ 0, 0 ≤ 𝑆
𝑀
+ 𝐿
𝑀
+ 𝐼
𝑀
≤ 𝑁
𝑀
,
𝑆
𝐸
= 𝑁
𝐸
≥ 0} .
(2)
Since the right-hand sides of equations of system (1) and
their partial derivatives are continuous in Ω, we will use the
techniques described in [21] that there exist a unique solution
𝑆
𝐻
(𝑡) + 𝑉
𝐻
(𝑡) + 𝐼
𝐻
(𝑡) + 𝑅
𝐻
(𝑡) = 𝑁
𝐻
(𝑡), 𝑆
𝑀
+ 𝐿
𝑀
(𝑡) + 𝐼
𝑀
(𝑡) =
𝑁
𝑀
(𝑡), and 𝑆
𝐸
(𝑡) = 𝑁
𝐸
(𝑡), for all 𝑡 ≥ 0, satisfying the initial
conditions specifiedwithinΩ, 𝑆
𝐻
(0)+𝑉
𝐻
(0)+𝐼
𝐻
(0)+𝑅
𝐻
(0) =
𝑁
𝐻
(0), 𝑆
𝑀
(0) + 𝐿
𝑀
(0) + 𝐼
𝑀
(0) = 𝑁
𝑀
(0), and 𝑆
𝐸
(0) = 𝑁
𝐸
(0),
at time 𝑡 = 0. It can also be verified that the given initial
conditions make sure that𝑁
𝐻
≥ 0.Thus, the total population
𝑁
𝐻
remains positive and bounded for all finite time 𝑡 >
0. Similar arguments can be applied to both mosquito and
eggs equations with corresponding expressions.Therefore, all
solutions of the model with initial conditions in Ω remain
in Ω for all 𝑡 ≥ 0, the region Ω is positively invariant
with respect to model (1), and its solutions are considered
epidemiologically and mathematically well posed in Ω.
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3. The Existence of Equilibria
Our next result concerns the existence of equilibrium points
of system (1) that are biologically feasible. Thus, we will find
the equilibrium points of system (1) in the regionΩ by setting
right hand side of all equations in it as equal to zero. First
of all, we will seek the conditions for the existence of the
equilibria of system (1) which are biologically feasible.
From the second and fourth equations of (1) with the
right-hand side equal to zero, it can be seen that the
equilibrium points must satisfy, respectively, the following
relations:
𝑉
∗
𝐻
= 𝜌vac𝑁
∗
𝐻
[1 −
(𝜇
𝐻
+ 𝛾
𝐻
)
𝜇
𝐻
𝐼
∗
𝐻
𝑁
∗
𝐻
] , (3)
𝑅
∗
𝐻
=
𝛾
𝐻
𝜇
𝐻
𝐼
∗
𝐻
, (4)
where
0 < 𝜌vac =
𝑓
𝐻
]
𝐻
𝑓
𝐻
]
𝐻
+ 𝜇
𝐻
+ 𝜔
𝐻
< 1, (5)
𝑉
∗
𝐻
> 0 ⇐⇒
𝐼
∗
𝐻
𝑁
∗
𝐻
<
𝜇
𝐻
𝜇
𝐻
+ 𝛾
𝐻
< 1 󳨐⇒ 𝐼
∗
𝐻
< 𝑁
∗
𝐻
. (6)
Therefore, 𝑉∗
𝐻
> 0 is always satisfied.
Substituting (3) and (4) into the third equation of system
(1), we obtain
𝐼
∗
𝑀
=
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) 𝐼
∗
𝐻
𝑎𝑏 (1 − 𝜌vac) {1 − [(1 + 𝛾𝐻/𝜇𝐻) (𝐼
∗
𝐻
/𝑁
∗
𝐻
)]}
, (7)
𝐼
∗
𝑀
> 0 ⇐⇒
𝐼
∗
𝐻
𝑁
∗
𝐻
<
𝜇
𝐻
𝜇
𝐻
+ 𝛾
𝐻
< 1 󳨐⇒ 𝐼
∗
𝐻
< 𝑁
∗
𝐻
. (8)
Hence, 𝐼∗
𝑀
> 0 is also always satisfied.
From eighth and ninth equations of system (1), we obtain
𝐿
∗
𝑀
=
𝜇
𝑀
𝛾
𝑀
𝐼
∗
𝑀
, (9)
𝑁
∗
𝑀
=
𝑝𝑐
𝑆
𝜇
𝑀
𝑆
∗
𝐸
. (10)
From tenth equation of system (1), we get either 𝑆∗
𝐸
= 0 or
𝑆
∗
𝐸
= 𝑘
𝐸
[1 −
𝜇
𝑀
𝜇
thres
𝑀
] , (11)
with 𝜇thres
𝑀
= 𝑟
𝑀
𝑝𝑐
𝑆
/(𝜇
𝐸
+𝑝𝑐
𝑆
). From expression (11) it follows
that
𝑆
∗
𝐸
> 0 ⇐⇒ 𝜇
𝑀
< 𝜇
thres
𝑀
. (12)
Later we will see that for 𝑆∗
𝐸
= 0 only the trivial equilibrium
can exist, while for 𝑆∗
𝐸
> 0, given by (11), both the trivial and
the nontrivial equilibrium may exist for system (1).
Substituting (9) into the seventh equation of system (1),
we obtain
𝐼
∗
𝑀
=
𝑎𝑐𝑁
∗
𝑀
(𝐼
∗
𝐻
/𝑁
∗
𝐻
)
(𝑎𝑐 (𝐼
∗
𝐻
/𝑁
∗
𝐻
) + 𝜇
𝑀
) (1 + 𝜇
𝑀
/𝛾
𝑀
)
. (13)
From (7) and (13) we obtain either 𝐼∗
𝐻
= 0 or
𝐼
∗
𝐻
= (𝑎
2
𝑏𝑐𝛾
𝑀
(1 − 𝜌vac)𝑁
∗
𝑀
− (𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝛾
𝑀
+ 𝜇
𝑀
) 𝜇
𝑀
𝑁
∗
𝐻
)
⋅ (𝑎
2
𝑏𝑐𝛾
𝑀
(1 +
𝛾
𝐻
𝜇
𝐻
) (𝛾
𝑀
+ 𝜇
𝑀
) (1 − 𝜌vac)
𝑁
∗
𝑀
𝑁
∗
𝐻
+ 𝑎𝑐 (𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝛾
𝑀
+ 𝜇
𝑀
))
−1
.
(14)
From expression (14), it should be noted that, for 𝜇
𝑀
<
𝜇
thres
𝑀
, 𝐼∗
𝐻
> 0 whenever
𝑎
2
𝑏𝑐𝛾
𝑀
𝑁
∗
𝑀
𝜇
𝑀
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝛾
𝑀
+ 𝜇
𝑀
)𝑁
∗
𝐻
>
1
(1 − 𝜌vac)
, (15)
or
0 < 𝑁
∗
𝐻
<
𝑎
2
𝑏𝑐𝑝𝑐
𝑆
𝛾
𝑀
𝑘
𝐸
(𝜇
𝑀
)
2
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝛾
𝑀
+ 𝜇
𝑀
)
⋅ (1 −
𝜇
𝑀
𝜇
thres
𝑀
) (1 − 𝜌vac) = 𝑁1.
(16)
On the other hand, from fifth equation of system (1), we
also get
𝐼
∗
𝐻
= [
𝑟
𝐻
𝛼
𝐻
(1 −
𝑁
∗
𝐻
𝑘
𝐻
) −
𝜇
𝐻
𝛼
𝐻
]𝑁
∗
𝐻
, (17)
and 𝐼∗
𝐻
> 0 whenever
0 < 𝑁
∗
𝐻
<
𝑘
𝐻
(𝑟
𝐻
− 𝜇
𝐻
)
𝑟
𝐻
= 𝑁
2
with 𝑟
𝐻
> 𝜇
𝐻
. (18)
From expressions (16) and (18), one can note, however,
that, 𝑁
2
is the maximum value of 𝑁∗
𝐻
, so it follows that
𝑁
1
< 𝑁
2
and 𝐼∗
𝐻
> 0 if and only if condition (18) holds.
Furthermore, for 𝐼∗
𝐻
> 0 the system (1) reaches an endemic
equilibrium point.
In contrast, from (4), (9), (13), and (18), 𝐼∗
𝐻
= 0 leads to
𝑁
∗
𝐻
= 𝑁
2
, 𝐼
∗
𝑀
= 0, 𝐿
∗
𝑀
= 0,
𝑉
∗
𝐻
= 𝜌vac𝑁
∗
𝐻
, 𝑆
∗
𝐻
= 𝑁
∗
𝐻
− 𝑉
∗
𝐻
, 𝑅
∗
𝐻
= 0,
(19)
where 𝑆∗
𝐸
= 𝑁
∗
𝐸
̸= 0 and 𝑆∗
𝑀
= 𝑁
∗
𝑀
̸= 0 are also given by
expressions (10) and (11), respectively. Therefore, for 𝐼∗
𝐻
= 0
only the trivial equilibrium exists for system (1). To be more
specific, for 𝑆∗
𝐸
= 𝑁
∗
𝐸
̸= 0 and 𝑆∗
𝑀
= 𝑁
∗
𝑀
̸= 0 the trivial
equilibrium is given by the densities of humans and vectors,
while for 𝑆∗
𝐸
= 𝑁
∗
𝐸
= 0 and 𝑆∗
𝑀
= 𝑁
∗
𝑀
= 0 the trivial
equilibrium is given only by the density of humans.
Now, by substituting (14) in (18), it can be shown that
the nontrivial equilibria of the model satisfy the following
quadratic equation (in terms of𝑁∗
𝐻
):
𝑃 (𝑁
∗
𝐻
) = 𝑄
2
(𝑁
∗
𝐻
)
2
+ 𝑄
1
𝑁
∗
𝐻
+ 𝑄
0
= 0, (20)
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where
𝑄
2
= 𝑎𝑐𝜃𝑟
𝐻
,
𝑄
1
= 𝜃 (1 − 𝜌vac) (1 +
𝛾
𝐻
𝜇
𝐻
)𝑘
𝐻
(𝑟
𝐻
− 𝜇
𝐻
) 𝜇
𝑀
(𝑅
0
− Ψ) ,
𝑄
0
= 𝜏𝑘
𝐻
(𝜇
𝐻
+ 𝛾
𝐻
) (𝑟
thres
𝐻
− 𝑟
𝐻
) ,
(21)
with
𝜏 = 𝑎
2
𝑏𝑐𝑁
∗
𝑀
(1 − 𝜌vac) ,
𝜃 = (𝜇
𝐻
+ 𝛾
𝐻
+ 𝛼
𝐻
) (1 +
𝜇
𝑀
𝛾
𝑀
) ,
Ψ =
(𝛼
𝐻
− 𝑎𝑐) 𝜇
𝐻
(1 − 𝜌vac) (𝜇𝐻 + 𝛾𝐻) 𝜇𝑀
,
(22)
𝑟
thres
𝐻
=
𝜇
𝐻
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
)
(𝜇
𝐻
+ 𝛾
𝐻
)
, (23)
𝑅
0
=
𝑎
2
𝑏𝑐𝑝𝑐
𝑆
𝑘
𝐸
𝑟
𝐻
(𝜇
𝑀
)
2
𝜃𝑘
𝐻
(𝑟
𝐻
− 𝜇
𝐻
)
(1 −
𝜇
𝑀
𝜇
thres
𝑀
) , (24)
with 𝜇thres
𝑀
satisfying the condition given by (12).
The positive endemic equilibriumofmodel (1) is obtained
by solving for𝑁∗
𝐻
from the quadratic (20) and substituting the
results (positive values of 𝑁∗
𝐻
) into the expressions that give
the coordinates of equilibrium point.
First, it is straightforward to note that 𝑟thres
𝐻
given by
(23) and 𝜃 given by (22) are positive. Moreover, under
our assumption Ψ < 0 and 𝑄
1
is also positive. Clearly,
the coefficient 𝑄
2
of the quadratic equation (20) is always
positive.
Also, note that the coefficient 𝑄
0
is positive either if 𝜏 >
0 and 𝑟
𝐻
< 𝑟
thres
𝐻
or 𝜏 < 0 and 𝑟
𝐻
> 𝑟
thres
𝐻
. If 𝜏 < 0 then
𝜇
𝑀
> 𝜇
thres
𝑀
and the positive endemic equilibrium does not
exist (see (12)) for system (1). Later we will see that, for 𝜇
𝑀
>
𝜇
thres
𝑀
, the only equilibrium biologically feasible and stable is
the equilibrium given by 𝑃𝐻
0
.
Therefore, 𝑄
0
> 0 if and only if 𝜏 > 0 (i.e., 𝜇
𝑀
< 𝜇
thres
𝑀
)
and 𝑟
𝐻
< 𝑟
thres
𝐻
. In this case, if 𝑄
1
> 0, the quadratic
equation (20) does not have a positive solution. It follows
then that system (1) does not have positive endemic equilibria
whenever 𝑟
𝐻
< 𝑟
thres
𝐻
. In this case, note that the only
equilibrium biologically feasible and stable for system (1) is
the trivial equilibrium given by 𝑃𝐻𝑀
0
(see (19)).
Otherwise, 𝜏 > 0 (i.e., 𝜇
𝑀
< 𝜇
thres
𝑀
) but 𝑟
𝐻
> 𝑟
thres
𝐻
;
then 𝑄
0
< 0, so there is a unique positive real solution of
the quadratic equation (20), for any value of 𝑄
1
. Hence, for
𝑟
𝐻
> 𝜇
𝐻
and 𝜇
𝑀
< 𝜇
thres
𝑀
, the system (1) has a unique positive
endemic equilibrium when 𝑟
𝐻
> 𝑟
thres
𝐻
.
If𝑄
0
= 0 (i.e., 𝑟
𝐻
= 𝑟
thres
𝐻
) and𝑄
1
< 0 or𝑄2
1
− 4𝑄
1
𝑄
0
= 0,
then there is a unique positive real solution for the quadratic
equation (20), so the system (1) has a unique positive endemic
equilibrium when 𝑟
𝐻
= 𝑟
thres
𝐻
.
Therefore, for 𝑟
𝐻
> 𝜇
𝐻
, the above analysis indicates
the possibility of the existence of the following positive
equilibrium points for system (1):
(i) a disease-free equilibrium (DFE) defined only by
human population, 𝑃𝐻
0
= (𝑆0
𝐻
, 𝑉
0
𝐻
, 0, 0,𝑁
0
𝐻
, 0, 0,
0, 0, 0);
(ii) a disease-free equilibrium (DFE) defined by both
human and vector populations defined by 𝑃𝐻𝑀
0
=
(𝑆
0
𝐻
, 𝑉
0
𝐻
, 0, 0,𝑁
0
𝐻
, 𝑆
0
𝑀
, 0, 0,𝑁
0
𝑀
, 𝑆
0
𝐸
);
(iii) an endemic equilibrium (EE) point biologically
feasible given by 𝑃𝐻𝑀
1
= (𝑆∗
𝐻
, 𝐼
∗
𝐻
, 𝑅
∗
𝐻
, 𝑉
∗
𝐻
, 𝑁
∗
𝐻
, 𝑆
∗
𝑀
,
𝐿
∗
𝑀
, 𝐼
∗
𝑀
, 𝑁
∗
𝑀
, 𝑆
∗
𝐸
).
Quite apart from this, the existence of the positive
equilibrium points for the system (1) can be also summarized
as follows.
Theorem 1. Assuming that 𝑟
𝐻
> 𝜇
𝐻
holds, model (1) has
a unique disease-free equilibrium 𝑃𝐻
0
whenever 𝜇
𝑀
> 𝜇
𝑡ℎ𝑟𝑒𝑠
𝑀
.
Otherwise, if 𝜇
𝑀
< 𝜇
𝑡ℎ𝑟𝑒𝑠
𝑀
then model (1) has the trivial
equilibrium 𝑃𝐻𝑀
0
and the endemic equilibrium 𝑃𝐻𝑀
1
. For 𝑟
𝐻
<
𝑟
𝑡ℎ𝑟𝑒𝑠
𝐻
, the unique equilibrium that exists is given by the trivial
equilibrium 𝑃𝐻𝑀
0
. Otherwise, for 𝑟
𝐻
> 𝑟
𝑡ℎ𝑟𝑒𝑠
𝐻
, both the trivial
equilibrium, 𝑃𝐻𝑀
0
, and the endemic equilibrium, 𝑃𝐻𝑀
1
, exist.
Having found the scenarios in which there exist the
equilibria for the system (1), it is instructive to analyse
whether or not these equilibria are stable under any of
these scenarios. Furthermore, together with the threshold
vaccination rate, ]𝐶
𝐻
, and the reproduction number, 𝑅vac, we
will see that each scenario can be used as a check for the
existence, the uniqueness, and the stability of all equilibria.
This is explored below for 𝑟
𝐻
> 𝜇
𝐻
.
3.1. Disease-Free Equilibria. In the absence of the disease, that
is, 𝑅0
𝐻
= 𝐼
0
𝐻
= 𝐼
0
𝑀
= 𝐿
0
𝑀
= 0 and for 𝑟
𝐻
> 𝜇
𝐻
, model (1)
has two disease-free equilibria given by 𝑃𝐻
0
and 𝑃𝐻𝑀
0
. Thus,
if 𝜇
𝑀
< 𝜇
thres
𝑀
, then the disease-free equilibrium is given
by 𝑃𝐻𝑀
0
:
𝑆
0
𝐻
=
𝑘
𝐻
(𝑟
𝐻
− 𝜇
𝐻
)
𝑟
𝐻
(1 − 𝜌vac) ,
𝑉
0
𝐻
= 𝜌vac𝑁
0
𝐻
,
𝑁
0
𝐻
=
𝑘
𝐻
(𝑟
𝐻
− 𝜇
𝐻
)
𝑟
𝐻
,
𝑆
0
𝑀
= 𝑁
0
𝑀
=
𝑝𝑐
𝑆
𝜇
𝑀
𝑆
0
𝐸
,
𝑆
0
𝐸
= 𝑘
𝐸
[1 −
𝜇
𝑀
𝜇
thres
𝑀
] ,
(25)
where 𝜌vac is defined by expression (5). In contrast, if 𝜇𝑀 >
𝜇
thres
𝑀
, then the only equilibrium biologically viable is 𝑃𝐻
0
,
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which is also given by (25), but with 𝑆(0)
𝑀
= 𝑁
(0)
𝑀
= 𝑆
(0)
𝐸
=
𝑁
(0)
𝐸
= 0.
To establish the stability of both trivial equilibrium,
the Jacobian of the system (1) is computed and evaluated
at both 𝑃𝐻
0
and 𝑃𝐻𝑀
0
. We will discuss the properties of
both trivial equilibrium points making an elementary row-
transformation for the Jacobian matrix.
Evaluating the system’s Jacobian at 𝑃𝐻
0
, the local stability
of 𝑃𝐻
0
is straightforward determined by the six eigenvalues
given by 𝜏
1
= 𝜏
2
= −𝜇
𝑀
, 𝜏
3
= −𝜇
𝐻
, 𝜏
4
= −(𝜇
𝑀
+ 𝛾
𝑀
), 𝜏
5
=
−(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
), and 𝜏
6
= (𝜇
𝐻
− 𝑟
𝐻
) < 0 since 𝑟
𝐻
> 𝜇
𝐻
. The
other eigenvalues are expressed as the roots of the following
submatrix:
𝑀
𝑃
𝐻
0
=
[
[
[
[
[
[
− (𝑓
𝐻
]
𝐻
+ 𝜇
𝐻
) 𝜔
𝐻
0 0
𝑓
𝐻
]
𝐻
− (𝜔
𝐻
+ 𝜇
𝐻
) 0 0
0 0 − 𝜇
𝑀
𝑝𝑐
𝑆
0 0 𝑟
𝑀
− (𝜇
𝐸
+ 𝑝𝑐
𝑆
)
]
]
]
]
]
]
,
(26)
where
𝑀
0
𝐻
= [
− (𝑓
𝐻
]
𝐻
+ 𝜇
𝐻
) 𝜔
𝐻
𝑓
𝐻
]
𝐻
− (𝜔
𝐻
+ 𝜇
𝐻
)
] ,
𝑀
1
𝐻
= [
−𝜇
𝑀
𝑝𝑐
𝑆
𝑟
𝑀
− (𝜇
𝐸
+ 𝑝𝑐
𝑆
)
] .
(27)
It is easy to verify that both the traces of the matrices
tr(𝑀0
𝐻
) and tr(𝑀1
𝐻
) are always negative. Moreover, the
determinant of the matrix, det(𝑀0
𝐻
), is always positive, but
det(𝑀1
𝐻
) is positive if and only if 𝜇
𝑀
> 𝜇
thres
𝑀
. In other words,
it means that the four eigenvalues of matrix𝑀𝑃
𝐻
0 are either
negative or have negative real part whenever 𝜇
𝑀
> 𝜇
thres
𝑀
.
Therefore, all the eigenvalues of the characteristic equa-
tion associated with the system (1) at 𝑃𝐻
0
have negative real
parts if and only if 𝜇
𝑀
> 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝜇
𝐻
. We state then
the following result.
Lemma 2. For 𝑟
𝐻
> 𝜇
𝐻
, the disease-free equilibrium 𝑃𝐻
0
of model (1) is globally asymptotically stable if 𝜇
𝑀
> 𝜇
𝑡ℎ𝑟𝑒𝑠
𝑀
.
Otherwise, 𝑃𝐻
0
is unstable.
The stability of the disease-free equilibrium 𝑃𝐻𝑀
0
is now
examined by linearizing the system (1) around 𝑃𝐻𝑀
0
. The
characteristic equation of the Jacobian matrix of the system
(1) at 𝑃𝐻𝑀
0
is given by
Λ
1
{[−𝜇
𝑀
− 𝜆] [− (𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) − 𝜆] [− (𝜇
𝑀
+ 𝛾
𝑀
) − 𝜆]
+𝜒
1
}𝑀
𝑃
𝐻𝑀
0 = 0,
(28)
where
Λ
1
= [−𝜇
𝐻
− 𝜆] [−𝜇
𝑀
− 𝜆] [(𝜇
𝐻
− 𝑟
𝐻
) − 𝜆] , (29)
𝜒
1
= 𝑎
2
𝑏𝑐𝛾
𝑀
𝑆
0
𝐻
𝑆
0
𝑀
(𝑁
0
𝐻
)
2
, (30)
with 𝑆0
𝐻
, 𝑆0
𝑀
, and𝑁0
𝐻
given by (25) and
𝑀
𝑃
𝐻𝑀
0 =
[
[
[
[
[
[
[
[
[
− (𝑓
𝐻
]
𝐻
+ 𝜇
𝐻
) 𝜔
𝐻
0 0
𝑓
𝐻
]
𝐻
− (𝜔
𝐻
+ 𝜇
𝐻
) 0 0
0 0 −𝜇
𝑀
𝑝𝑐
𝑆
0 0 𝑟
𝑀
(1 −
𝑆
0
𝐸
𝑘
𝐸
) − (𝜇
𝐸
+ 𝑝𝑐
𝑆
) −
𝑟
𝑀
𝑘
𝐸
𝑁
0
𝑀
]
]
]
]
]
]
]
]
]
, (31)
where𝑀0
𝐻𝑀
= 𝑀
0
𝐻
(see (27)) and
𝑀
1
𝐻𝑀
=
[
[
[
−𝜇
𝑀
𝑝𝑐
𝑆
𝑟
𝑀
(1 −
𝑆
0
𝐸
𝑘
𝐸
) − (𝜇
𝐸
− 𝑝𝑐
𝑆
) −
𝑟
𝑀
𝑘
𝐸
𝑁
0
𝑀
]
]
]
. (32)
From (29) it is easy to verify that 𝜆
1
= −𝜇
𝐻
, 𝜆
2
= −𝜇
𝑀
,
𝜆
3
= (𝜇
𝐻
− 𝑟
𝐻
) < 0, since 𝑟
𝐻
> 𝜇
𝐻
. Moreover, from
(27) and (32), both the traces of the matrices tr(𝑀0
𝐻𝑀
) and
tr(𝑀1
𝐻𝑀
) are always negative; the determinant of the matrix,
det(𝑀0
𝐻𝑀
), is also always positive, but det(𝑀1
𝐻𝑀
) is positive
if and only if 𝜇
𝑀
< 𝜇
thres
𝑀
. Therefore, the four eigenvalues of
matrix𝑀𝑃
𝐻𝑀
0 are either negative or have negative real parts if
and only if 𝜇
𝑀
< 𝜇
thres
𝑀
.
The other three eigenvalues are associated with the third
degree equation in (28) given by
[−𝜇
𝑀
− 𝜆] ⌊− (𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) − 𝜆⌋ ⌊− (𝜇
𝑀
+ 𝛾
𝑀
) − 𝜆⌋
+ 𝜒
1
= 0.
(33)
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It can be seen after some calculations that the polynomial
(33) is equivalent to
𝜆
3
+ 𝑔
2
𝜆
2
+ 𝑔
1
𝜆 + 𝑔
0
= 0, (34)
where
𝑔
2
= 𝜇
𝑀
+ (𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) + (𝜇
𝑀
+ 𝛾
𝑀
) ,
𝑔
1
= 𝜇
𝑀
[(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) + (𝜇
𝑀
+ 𝛾
𝑀
)]
+ (𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝜇
𝑀
+ 𝛾
𝑀
) ,
𝑔
0
= 𝜇
𝑀
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝜇
𝑀
+ 𝛾
𝑀
) [1 − 𝑅vac] ,
(35)
𝑅vac = 𝑅0 [1 − 𝜌vac] , (36)
with 𝜌vac < 1 given by (5); 𝑅0 is the threshold quantity or the
basic reproductive number of the diseases defined by (23) and
𝑅vac < 𝑅0. It is worth remembering that 𝑃
𝐻𝑀
0
given by (25)
exists whenever 𝑟
𝐻
> 𝜇
𝐻
and 𝜇
𝑀
< 𝜇
thres
𝑀
, so 𝑅
0
> 0 and
𝑅vac > 0.
By using the Routh-Hurwitz criteria for the polynomial
(33), it follows that 𝑔
2
> 0, 𝑔
1
> 0, and 𝑔
0
> 0 if and only if
𝑅vac < 1 and 𝑔1𝑔2 − 𝑔0 > 0. Therefore, the polynomial (33)
has negative (or has negative real part) roots if 𝑅vac < 1.
Hence, for 𝑟
𝐻
> 𝜇
𝐻
, all the eigenvalues of the characteris-
tic equation associatedwith the system (1) at𝑃𝐻𝑀
0
are negative
or have negative real parts if and only if 𝜇
𝑀
< 𝜇
thres
𝑀
and
𝑅vac < 1. Hence, the disease-free equilibrium 𝑃
𝐻𝑀
0
is locally
asymptotically stable when 𝑅vac < 1 and 𝜇𝑀 < 𝜇
thres
𝑀
.
It is worth remembering that if 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
<
𝑟
thres
𝐻
there are no positive solutions of the quadratic equation
(20) and thus there is no endemic equilibrium of system (1).
However, by (19), it follows that the disease-free equilibrium
𝑃
𝐻𝑀
0
is the only equilibriumpoint that exists when 𝑟
𝐻
< 𝑟
thres
𝐻
.
Otherwise, for 𝑟
𝐻
> 𝑟
thres
𝐻
, there is a unique positive real
solution of the quadratic equation (20) which indicates the
possibility of a unique positive endemic equilibrium given by
𝑃
𝐻𝑀
1
. On the other hand, from (25) it can be also noted that
the existence of the disease-free equilibrium 𝑃𝐻𝑀
0
does not
depend on 𝑟thres
𝐻
, and thus 𝑃𝐻𝑀
0
could also exist in this case.
Therefore, the disease-free equilibrium 𝑃𝐻𝑀
0
coexists with an
endemic equilibrium 𝑃𝐻𝑀
1
whenever 𝑟
𝐻
> 𝑟
thres
𝐻
.
It follows from above analyses that the disease-free
equilibrium 𝑃𝐻𝑀
0
is a unique equilibrium which is locally
asymptotically stable whenever 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
< 𝑟
thres
𝐻
.
In such a scenario, disease elimination would depend upon
the birth rate of humans, 𝑟
𝐻
, and the mosquitoes natural
mortality rate 𝜇
𝑀
. Otherwise, if 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝑟
thres
𝐻
,
then 𝑃𝐻𝑀
0
is locally asymptotically stable when 𝑅vac < 1. The
epidemiological implication of this is that the requirements of
𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝑟
thres
𝐻
are, although necessary, no longer
sufficient for disease elimination. The disease elimination
would depend upon the vaccination coverage (𝜐
𝐻
) and thus
will eliminate the disease from the population if the usage of
an imperfect vaccine results in making (and keeping) 𝑅vac <
1.
For the case when 𝜇
𝑀
< 𝜇
thres
𝑀
, for 𝑟
𝐻
< 𝑟
thres
𝐻
the
quadratic equation has no positive solution. Hence, system
(1) has no positive solution (endemic equilibrium) for 𝑟
𝐻
<
𝑟
thres
𝐻
. As the only existing equilibrium for 𝜇
𝑀
< 𝜇
thres
𝑀
is the
trivial one, 𝑃𝐻𝑀
0
, then we can conjecture that, for 𝑟
𝐻
< 𝑟
thres
𝐻
,
𝑃
𝐻𝑀
0
is the only possible equilibrium for system (1), being,
therefore, stable. On the other hand, for 𝑟
𝐻
> 𝑟
thres
𝐻
the
quadratic equation has a positive solution and hence, system
(1) shows an endemic equilibrium, 𝑃𝐻𝑀
1
. As the existence of
𝑃
𝐻𝑀
0
, however, does not depend on 𝑟thres
𝐻
(see (25)), we can
state that 𝑃𝐻𝑀
0
also exists for 𝑟
𝐻
> 𝑟
thres
𝐻
. In addition, if 𝑅vac <
1, then 𝑃𝐻𝑀
0
is stable. Note that, in all cases, the mosquito’s
mortality rate 𝜇
𝑀
is the critical parameter, in the absence of
vaccination, determining the stability of the disease.
How about the case when 𝑅vac > 1, 𝑃
𝐻𝑀
0
becomes
unstable? In this case, the critical value of vaccination is given
by (38); that is, if 𝜐
𝐻
> 𝜐
thres
𝐻
, then 𝑃𝐻𝑀
0
is stable. In contrast,
if 𝜐
𝐻
< 𝜐
thres
𝐻
, then 𝑃𝐻𝑀
0
is unstable and 𝑃𝐻𝑀
1
becomes stable.
We establish then the following stability result for the
system (1).
Lemma 3. For 𝑟
𝐻
> 𝜇
𝐻
and 𝜇
𝑀
< 𝜇
𝑡ℎ𝑟𝑒𝑠
𝑀
the disease-
free equilibrium of the model (1), 𝑃𝐻𝑀
0
, exists and it is locally
asymptotically stable if
(a) 𝑅V𝑎𝑐 < 1 and 𝑟𝐻 > 𝑟𝑡ℎ𝑟𝑒𝑠𝐻 ,
(b) 𝑟
𝐻
< 𝑟
𝑡ℎ𝑟𝑒𝑠
𝐻
,
(c) otherwise, 𝑃𝐻𝑀
0
is unstable.
The quantity 𝑅vac given by (36) is called the vaccinated
reproduction number, since it represents the expected aver-
age number of new infections produced by a single infective
when introduced into a human community where a fraction
of the susceptible population has been vaccinated. For a
disease in which the susceptible population is vaccinated
it has been demonstrated that 𝑅vac, which is the basic
reproduction number 𝑅
0
[26] modified by vaccination, must
be reduced below one in order to ensure that the disease dies
out [27]. If there is no vaccination, then 𝑅vac = 𝑅0. Therefore,
the aim of the vaccination must be to reduce 𝑅vac below one
and to provide prolonged protection against the infection.
Now, expression (36) for 𝑅vac can be written in terms of
𝑆
0
𝑀
,𝑁0
𝐻
, and 𝑆0
𝐻
such as
𝑅vac =
𝑎
2
𝑏𝑐𝛾
𝑀
(𝑆
0
𝑀
/𝑁
0
𝐻
)
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝜇
𝑀
+ 𝛾
𝑀
) (𝜇
𝑀
)
𝑆
0
𝐻
𝑁
0
𝐻
. (37)
Setting 𝑅vac = 1, and solving (37) for 𝜐𝐻, the threshold
vaccination rate is found to be
𝜐
thres
𝐻
=
(𝜇
𝐻
+ 𝜔
𝐻
)
𝑓
𝐻
(𝑅
0
− 1) . (38)
It is worth remembering that 𝑅
0
> 0 whenever 𝑟
𝐻
> 𝜇
𝐻
and 𝜇
𝑀
< 𝜇
thres
𝑀
(see (24)). More than that, 𝑅
0
< 1 implies
𝑅vac < 1 (see (36)), according to Lemma 3. 𝑃
𝐻𝑀
0
could be
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Table 3: Stability of the equilibrium points of the model (1) for 𝑟
𝐻
>
𝜇
𝐻
.
Conditions Equilibrium point
𝜇
𝑀
> 𝜇
thres
𝑀
𝑃
𝐻𝑀
0
= (𝑆
0
𝐻
, 𝑉
0
𝐻
, 0, 0, 0, 0, 0, 0)
stable
𝜇
𝑀
< 𝜇
thres
𝑀
, 𝑟
𝐻
< 𝑟
thres
𝐻
𝑃
𝐻𝑀
0
=
(𝑆
0
𝐻
, 𝑉
0
𝐻
, 0, 0, 0, 0,𝑁
∗
𝑀
, 𝑆
∗
𝐸
)
stable
𝜇
𝑀
< 𝜇
thres
𝑀
, 𝑟
𝐻
> 𝑟
thres
𝐻
, 𝜐
𝐻
> 𝜐
thres
𝐻
𝑃
𝐻𝑀
0
=
(𝑆
0
𝐻
, 𝑉
0
𝐻
, 0, 0, 0, 0,𝑁
∗
𝑀
, 𝑆
∗
𝐸
)
stable
𝜇
𝑀
< 𝜇
thres
𝑀
, 𝑟
𝐻
> 𝑟
thres
𝐻
, 𝜐
𝐻
< 𝜐
thres
𝐻
𝑃
𝐻𝑀
1
=
(𝑉
∗
𝐻
, 𝐼
∗
𝐻
, 𝑅
∗
𝐻
, 𝐿
∗
𝑀
, 𝐼
∗
𝑀
, 𝑁
∗
𝑀
, 𝑆
∗
𝐸
)
stable
stable. Therefore, the disease eradication can be attainable
independently of vaccination coverage, that is, even when
𝜐
thres
𝐻
= 0.
In contrast, if 𝑅
0
> 1, 𝜐thres
𝐻
is positive but we also have
either 𝑅vac > 1 or 𝑅vac < 1. In this situation, the disease
could be eliminated whenever 𝜐
𝐻
> 𝜐
thres
𝐻
and𝑃𝐻𝑀
0
is globally
asymptotically stable. Otherwise, when 𝜐
𝐻
< 𝜐
thres
𝐻
, the use
of an imperfect vaccine will fail to eliminate the disease from
the community,𝑃𝐻𝑀
0
is unstable, the diseasewill persist in the
community, and𝑃𝐻𝑀
1
becomes globally asymptotically stable.
Finally, concerning the analysis of the polynomial (20),
Lemmas 2 and 3, we can establish the following conjecture
for the system (1).
Conjecture 4. For 𝑟
𝐻
> 𝜇
𝐻
the disease-free equilibrium 𝑃𝐻
0
is
globally asymptotically stable if 𝜇
𝑀
> 𝜇
𝑡ℎ𝑟𝑒𝑠
𝑀
. If 𝜇
𝑀
< 𝜇
𝑡ℎ𝑟𝑒𝑠
𝑀
,
𝑃
𝐻
0
becomes unstable and for 𝑟
𝐻
< 𝑟
𝑡ℎ𝑟𝑒𝑠
𝐻
, 𝑃𝐻𝑀
0
is globally
asymptotically stable equilibrium point. If 𝑟
𝐻
> 𝑟
𝑡ℎ𝑟𝑒𝑠
𝐻
, then
𝑃
𝐻𝑀
0
is globally asymptotically stable if 𝜐
𝐻
> 𝜐
𝑡ℎ𝑟𝑒𝑠
𝐻
. Otherwise,
if 𝜐
𝐻
< 𝜐
𝑡ℎ𝑟𝑒𝑠
𝐻
, then 𝑃𝐻𝑀
0
becomes unstable and the globally
asymptotically equilibrium point stable is then given by 𝑃𝐻𝑀
1
.
The stability of the equilibrium points can then be
summarized in Table 3.
As it will be explained in detail below, it is important to
point out that by considering our model (1) without vaccine,
that is, taking ]
𝐻
= 𝑓
𝐻
= 𝜔
𝐻
= 0, we have 𝜌vac = 0; the first
term of expression (15) defines then the basic reproduction
number used to gauge the severity of an epidemic; it will be
denoted by 𝑅
0
.Therefore, according to inequality (15), 𝐼∗
𝐻
> 0
whenever
𝜌vac < 1 −
1
𝑅
0
. (39)
If 𝑅
0
< 1, 𝜌vac < 0, from (36), 𝑅vac > 1. If 𝑅0 = 1, 𝜌vac = 0,
from (36), 𝑅vac = 𝑅0. If 𝑅0 > 1, 0 < 𝜌vac < 1, from (36), either
𝑅vac > 1 or 𝑅0 < 1.
From (36) if vaccine has no effect, 𝜔
𝐻
→ ∞ (immune
protection duration, 𝐷 = 1/𝜔
𝐻
→ 0), then 𝑅vac increases
(𝑟
𝐻
< 𝑟
thres
𝐻
or 𝑟
𝐻
> 𝑟
thres
𝐻
). If the vaccine induces lifelong
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−3.771
−3.766
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Figure 2: For 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
< 𝑟
thres
𝐻
, the quadratic equation
𝑃(𝑁
∗
𝐻
) is plotted versus 𝜐
𝐻
, corresponding to two negative (which is
not biologically relevant) real roots.
immunity, then 𝜔
𝐻
= 0 (𝐷 → ∞), 0 < 𝜌vac ≤ 1, 𝑅vac > 1, or
𝑅
0
< 1 (see (36)).
4. Numerical Analysis
The numerical analysis of the stability of the equilibria was
done with the parameters of the model fixed at the baseline
values indicated in Table 2. We explore the implications of
variable vaccination coverage (𝜐
𝐻
), birth rate of humans
(𝑟
𝐻
), and mosquitoes natural mortality rate (𝜇
𝑀
) which are
chosen for simulations purposes only, so we can illustrate
our theoretical results. For the baseline parameters values in
Table 2, we have 𝑟thres
𝐻
= 0.000035085, 𝜇thres
𝑀
= 4.751131, and
𝜐
thres
𝐻
= 8.0117.
Figures 2 and 3 show the graph of (20), with 𝑃(𝑁∗
𝐻
)
plotted versus 𝜐
𝐻
. Figure 2 shows the graph for 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
< 𝑟
thres
𝐻
, with increasing values of 𝜐
𝐻
. One can see two
real negative roots of (20), which are not biologically viable
for the system (1). Therefore, the unique equilibrium point
that is biologically viable and locally asymptotically stable
is given by 𝑃𝐻𝑀
0
(see (19)). In this case, the disease can be
eradicated from the population. Figure 3 shows the graph for
𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝑟
thres
𝐻
, with increasing values of 𝜐
𝐻
.
One can see one positive and one negative real root of (20).
Hence, the system (1) has a unique endemic equilibrium𝑃𝐻𝑀
1
,
and the disease persists at an endemic level. Parameter values
used are as given in Table 2 (baseline values), except for 𝜐
𝐻
.
Figure 4 shows the graph of (37) for 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
>
𝑟
thres
𝐻
, with increasing values of 𝜐
𝐻
. Parameter values used are
as given in Table 2 (baseline values), except for 𝜐
𝐻
. For 𝜐
𝐻
>
𝜐
thres
𝐻
,𝑅vac < 1; the disease is then eradicated from population
(𝑃𝐻𝑀
0
is locally asymptotically stable). For 𝜐
𝐻
< 𝜐
thres
𝐻
, then
𝑅vac > 1; the disease persists into the population (𝑃
𝐻𝑀
1
is the
locally asymptotically stable).
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Figure 3: For 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝑟
thres
𝐻
, the quadratic equation
𝑃(𝑁
∗
𝐻
) is plotted versus 𝜐
𝐻
, corresponding to one negative (which is
not biologically relevant) and one positive real roots.
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Figure 4: For 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝑟
thres
𝐻
. If 𝜐
𝐻
> 𝜐
thres
𝐻
, then𝑅vac < 1;
if 𝜐
𝐻
< 𝜐
thres
𝐻
, then 𝑅vac > 1.
Figure 5 shows the prevalence of infectious individuals
as a function of 𝜐
𝐻
. All parameters values used are given
in Table 2 (baseline values), except for 𝜐
𝐻
. For 𝜐
𝐻
> 𝜐
thres
𝐻
,
𝐼
∗
𝐻
= 0, and 𝐼∗
𝑀
= 0; thus, 𝑃𝐻𝑀
0
is globally asymptotically
stable. For 𝜐
𝐻
< 𝜐
thres
𝐻
, then 𝐼∗
𝐻
̸= 0 and 𝐼∗
𝑀
̸= 0 and 𝑃𝐻𝑀
1
is
globally asymptotically stable.
Figures 6 and 7 show the profiles of both infectious
populations 𝐼∗
𝐻
and 𝐼∗
𝑀
. In Figure 6, for 𝜇
𝑀
< 𝜇
thres
𝑀
and
𝑟
𝐻
< 𝑟
thres
𝐻
there is no positive real solution of 𝑃(𝑁∗
𝐻
) and
the DFE 𝑃𝐻𝑀
0
is globally asymptotically stable. In Figure 7,
for 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝑟
thres
𝐻
the quadratic equation 𝑃(𝑁∗
𝐻
)
has one positive real solution. For 𝜐
𝐻
< 𝜐
thres
𝐻
, the endemic
equilibrium 𝑃𝐻𝑀
1
is, therefore, a unique equilibrium globally
asymptotically stable. Parameter values used are as given in
Table 2 (baseline values), except for 𝜇
𝑀
, 𝑟
𝐻
, and 𝜐
𝐻
.
5. Sensitivity Analysis
In this section, we present the sensitivity analysis of themodel
to find out the degree to which the parameters influence
the outputs of the model. Using the equation described in
[15, 28, 29], we investigate only two of the most significant
epidemiological concepts that affect the disease dynamics: the
force of infection and the prevalence of infection.
The force of infection is defined as [28, 29]
𝜆 = 𝑎𝑏
𝐼
∗
𝑀
𝑁
∗
𝐻
, (40)
where 𝑎 and 𝑏 are given in Table 2.Thus, substituting (7) into
expression (40) gives
𝜆 =
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝐼
∗
𝐻
/𝑁
∗
𝐻
)
(1 − 𝜌vac) {1 − (1 + 𝛾𝐻/𝜇𝐻) (𝐼
∗
𝐻
/𝑁
∗
𝐻
)}
. (41)
After some simple algebraic manipulations, (14) reduces
to
𝐼
∗
𝐻
𝑁
∗
𝐻
=
(1 − 𝜌vac) 𝑅
∗
− 1
𝑘
1
(1 − 𝜌vac) 𝑅
∗ + 𝑘
2
, (42)
where 𝑘
1
= (1 + 𝛾
𝐻
/𝜇
𝐻
)(𝜇
𝑀
+ 𝛾
𝑀
), 𝑘
2
= 𝑎𝑐/𝜇
𝑀
, and
the basic reproduction number of the diseases, 𝑅
0
, is being
approximated by
𝑅
∗
=
𝑎
2
𝑏𝑐𝛾
𝑀
(𝑆
∗
𝑀
/𝑁
∗
𝐻
)
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
) (𝜇
𝑀
+ 𝛾
𝑀
) (𝜇
𝑀
)
, (43)
since𝑁0
𝐻
≅ 𝑁
∗
𝐻
and 𝑆0
𝑀
≅ 𝑆
∗
𝑀
(see (37)).
In fact, 𝑆∗
𝑀
and 𝑁∗
𝐻
are smaller than 𝑆0
𝑀
and 𝑁0
𝐻
,
respectively. This is due to the fact that, in the endemic
equilibrium, the disease “consumes” the susceptible and total
population. As the prevalence of yellow fever is typically low,
the approximation holds.
Note that since 0 < 𝜌vac < 1, (42) is satisfied whenever
𝜌vac < 1 − 1/𝑅
∗, that is, whenever 𝑅∗ > 1. In this case,
the endemic equilibrium 𝑃𝐻𝑀
1
is a unique equilibrium which
is locally asymptotically stable. Moreover, we define 𝐼∗
𝐻
/𝑁
∗
𝐻
,
given by (42), as a prevalence for model (1), and denote it by
prev.
Now, applying the expression given by [15, 28, 29] to
estimate the sensitivity of a variables 𝑉
𝑖
to the parameters 𝜃
𝑗
,
Δ𝑉
𝑖
𝑉
𝑖
=
𝜃
𝑗
𝑉
𝑖
𝜕𝑉
𝑖
𝜕𝜃
𝑗
Δ𝜃
𝑗
𝜃
𝑗
, (44)
we can then calculate the sensitivity of both the force of
infection 𝜆 (see (40)) and the prevalence (see (42)), for the
parameter 𝜌vac, which are given by
Δ𝜆
𝜆
=
𝜌vac
𝜆
(𝜇
𝐻
+ 𝛼
𝐻
+ 𝛾
𝐻
)
[(1 + 𝛾
𝐻
/𝜇
𝐻
) (𝜌vac + prev − 1) − 1]
Δ𝜌vac
𝜌vac
,
Δprev
prev
=
𝜌vac
prev
Δ𝜌vac
𝜌vac
,
(45)
with Δ𝜌vac/𝜌vac = 0.01.
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Figure 5: Prevalence of (a) infectious individuals (𝐼∗
𝐻
) and (b) infectious mosquitoes (𝐼∗
𝑀
) as a function of 𝜐
𝐻
. 𝑃𝐻𝑀
0
is a unique equilibrium
globally asymptotically stable for 𝜐
𝐻
> 𝜐
thres
𝐻
and 𝑃𝐻𝑀
1
is globally asymptotically stable for 𝜐
𝐻
< 𝜐
thres
𝐻
.
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Figure 6: For 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
< 𝑟
thres
𝐻
, 𝑃𝐻𝑀
0
is a unique equilibrium globally asymptotically stable for any vaccination coverage, 𝜐
𝐻
. (a)
Profile of population of both infectious humans (𝐼∗
𝐻
) and mosquitoes (𝐼∗
𝑀
). (b) 𝐼∗
𝐻
is plotted versus 𝐼∗
𝑀
. The system approaches 𝐼∗
𝐻
= 0 and
𝐼
∗
𝑀
= 0, that is, the system approaches DFE, 𝑃𝐻𝑀
0
.
Finally, applying (45) to estimate the sensitivity of force of
infection and the prevalence to the vaccination effort (𝜌vac)
we can show that for every 1% of variation in 𝜌vac results in
a variation of approximated 0.6% and 844% in 𝜆 and prev,
respectively. Therefore, the prevalence is 1400 more sensitive
to vaccination than the force of infection. All parameters
values used are given in Table 2 (baseline values).
6. Summary and Conclusions
In this paper, we have formulated a model for yellow fever
disease with both human and vector populations as variables.
We found four threshold parameters that control the devel-
opment of the disease and the infectious status of the human
population in the presence of a preventive vaccine whose
protection may wane over time.
Our analysis is based on the assumption that the growth
rate of the human population is positive, that is, 𝑟
𝐻
− 𝜇
𝐻
> 0,
which is the case of the yellow fever affected populations.We,
therefore, can conclude the following:
(a) if the mortality rate of the mosquitoes is greater
than the threshold, 𝜇
𝑀
> 𝜇
thres
𝑀
, then the disease is
naturally (without intervention) eradicated from the
population;
(b) if, in contrast, the mortality rate of the mosquitoes
is less than the threshold, 𝜇
𝑀
< 𝜇
thres
𝑀
, then the
disease is eradicated from the populations only when
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Figure 7: For 𝜇
𝑀
< 𝜇
thres
𝑀
and 𝑟
𝐻
> 𝑟
thres
𝐻
, 𝑃𝐻𝑀
1
is a unique equilibrium locally asymptotically stable for 𝜐
𝐻
< 𝜐
thres
𝐻
. (a) Profile of populations
of both infectious humans (𝐼∗
𝐻
) and mosquitoes (𝐼∗
𝑀
). (b) 𝐼∗
𝐻
is plotted versus 𝐼∗
𝑀
. The system approaches 𝐼∗
𝐻
̸= 0 and 𝐼∗
𝑀
̸= 0, that is, the
system approaches endemic equilibrium, 𝑃𝐻𝑀
1
.
the growing rate of humans is less than a threshold,
𝑟
𝐻
< 𝑟
thres
𝐻
. Otherwise, 𝑟
𝐻
> 𝑟
thres
𝐻
; then the disease is
eradicated only if 𝑅vac < 1;
(c) in case 𝑅vac > 1, then the disease will be eradicated
from the human population if the vaccination rate
is greater than a threshold, 𝜐
𝐻
> 𝜐
thres
𝐻
. Otherwise,
𝜐
𝐻
< 𝜐
thres
𝐻
; then the disease will establish itself among
humans, reaching a stable endemic equilibrium. This
conclusion derives from a rearrangement of (37); that
is,
𝑅vac = 𝑅0 [1 − 𝜌vac] > 1 󳨐⇒ (1 − 𝜌vac) >
1
𝑅
0
=
𝑆
∗
𝑁
; (46)
or in words, the vaccination effort should be such that
1 minus it should be greater than the proportion of
susceptible at equilibrium;
(d) the prevalence is 1400 more sensitive to vaccination
than the force of infection.
The model and analyses presented in this paper are
intended to serve as a framework for testing alternative
vaccination schedules taking into account the vaccine and
disease induced mortality rates. This will be the subject of a
future publication
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